Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19
GS-441524 is an adenosine analog and the parent nucleoside of the prodrug remdesivir, which has received emergency approval for treatment of COVID-19. Recently, GS-441524 has been proposed to be effective in the treatment of COVID-19, perhaps even being superior to remdesivir for treatment of this d...
Main Authors: | Henrik Berg Rasmussen, Gesche Jürgens, Ragnar Thomsen, Olivier Taboureau, Kornelius Zeth, Poul Erik Hansen, Peter Riis Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/7/1369 |
Similar Items
-
The usefulness of the adenosine deaminase assay for diagnosing tuberculosis pleuritis in immunocompromised patients at Dr George Mukhari tertiary laboratory, Pretoria
by: Molaudzi, Mulalo
Published: (2013) -
The Inside Story of Adenosine
by: Marcella Camici, et al.
Published: (2018-03-01) -
Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis
by: Sarah Jones, et al.
Published: (2021-07-01) -
Health Benefits of Methylxanthines in Cacao and Chocolate
by: Rafael Franco, et al.
Published: (2013-10-01) -
Functional Analysis of Putative Adenosine Recycling Enzymes in Arabidopsis thaliana
by: Engel, Katja
Published: (2009)